Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-23 Sale | 2025-10-27 5:19 pm | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner | 1,000,000 | $1.52 | $1,520,000 | 4,975,291 (Indirect) | View |
| 2025-10-08 Purchase | 2025-10-10 8:06 pm | Adicet Bio Inc. | ACET | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership 10% Owner | 5,000,000 | $1 | $5,000,000 | 7,420,781 (Indirect) | View |
| 2025-09-10 Sale | 2025-09-12 5:09 pm | PMV Pharmaceuticals Inc. | PMVP | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner | 500,000 | $1.8 | $900,000 | 5,975,291 (Indirect) | View |
| 2025-08-25 Purchase | 2025-09-02 9:52 pm | Shattuck Labs Inc. | STTK | ORBIMED ADVISORS LLC OrbiMed Capital GP IX LLC OrbiMed Genesis GP LLC Director | 6,306,127 | $0.8677 | $5,471,826 | 31,624,470 (Indirect) | View |
| 2025-06-27 Sale | 2025-07-01 9:23 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,176,332 | $4.1586 | $4,891,894 | 7,165,006 (Indirect) | View |
| 2025-06-24 Sale | 2025-06-26 5:10 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 583,657 | $0.33794 | $197,239 | 6,066,343 (Indirect) | View |
| 2025-05-14 Sale | 2025-05-16 5:26 pm | NeuroPace Inc | NPCE | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 168,136 | $15.85 | $2,665,333 | 3,238,199 (Indirect) | View |
| 2025-04-22 Sale | 2025-04-24 5:38 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 235,572 | $0.33421 | $78,731 | 6,650,000 (Indirect) | View |
| 2025-04-15 Sale | 2025-04-17 6:10 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 149,054 | $0.33346 | $49,704 | 6,885,572 (Indirect) | View |
| 2025-04-10 Sale | 2025-04-14 7:14 pm | Xtant Medical Holdings Inc. | XTNT | ORBIMED ADVISORS LLC Orbimed ROF II LLC 10% Owner | 73,114,592 | $0.42 | $30,708,129 | 0 (Indirect) | View |
| 2025-04-09 Sale | 2025-04-11 7:24 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 3,571,428 | $1.59 | $5,678,571 | 15,219,994 (Indirect) | View |
| 2025-04-03 Purchase | 2025-04-04 7:33 pm | Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner | 496,771 | $20.13 | $10,000,000 | 443,792 (Indirect) | View |
| 2025-03-24 Sale | 2025-03-26 7:00 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 5,738 | $54.11 | $310,483 | 186,541 (Indirect) | View |
| 2025-03-19 Sale | 2025-03-21 8:00 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 52,429 | $54.02 | $2,831,987 | 187,297 (Indirect) | View |
| 2025-03-10 Sale | 2025-03-12 9:34 pm | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 312,384 | $54.31 | $16,965,596 | 194,209 (Indirect) | View |
| 2025-02-14 Purchase | 2025-02-19 5:52 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 190,672 | $10.6 | $2,020,756 | 747,887 (Indirect) | View |
| 2025-02-10 Purchase | 2025-02-10 4:28 pm | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 550,000 | $18 | $9,900,000 | 3,704,959 (Indirect) | View |
| 2025-01-10 Sale | 2025-01-14 5:17 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 223,219 | $0.63715 | $142,223 | 7,034,626 (Indirect) | View |
| 2025-01-06 Sale | 2025-01-08 6:09 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 147,024 | $0.70265 | $103,306 | 7,257,845 (Indirect) | View |
| 2024-12-20 Sale | 2024-12-26 4:34 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 230,321 | $0.6 | $138,193 | 7,404,869 (Indirect) | View |
| 2024-12-09 Sale | 2024-12-11 5:32 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 62,276 | $0.8348 | $51,988 | 7,635,190 (Indirect) | View |
| 2024-12-04 Sale | 2024-12-06 7:07 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 97,103 | $0.79646 | $77,338 | 7,697,466 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-17 4:17 pm | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 825,000 | $17 | $14,025,000 | 4,554,873 (Indirect) | View |
| 2024-09-19 Sale | 2024-09-23 4:51 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 39,300 | $0.71 | $27,903 | 7,794,569 (Indirect) | View |
| 2024-09-16 Sale | 2024-09-18 6:38 pm | Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner | 200,131 | $0.73315 | $146,727 | 7,833,869 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-17 8:13 pm | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 750,000 | $16 | $12,000,000 | 653,787 (Indirect) | View |
| 2024-08-26 Sale | 2024-08-28 4:26 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) | View |
| 2024-08-21 Sale | 2024-08-23 6:38 pm | ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director | 868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) | View |
| 2024-08-13 Sale | 2024-08-15 5:01 pm | Keros Therapeutics Inc. | KROS | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2024-08-13 Purchase | 2024-08-15 4:51 pm | scPharmaceuticals Inc. | SCPH | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC 10% Owner | 500,000 | $4 | $2,000,000 | 252,858 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-08 Equity Swap | 2025-08-12 5:22 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director | 3,099,265 | $0 | 0 (Indirect) | View |
| 2025-07-25 Option Award | 2025-07-30 9:30 pm | N/A N/A | ImageneBio Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 83,611 | $2.49 | 773,754 (Indirect) | View |
| 2025-06-27 Exercise | 2025-07-01 9:23 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,397,684 | $3.5 | 7,165,006 (Indirect) | View |
| 2025-06-27 Exercise | 2025-07-01 9:23 pm | 2025-04-29 2025-06-30 | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,397,684 | $0 | 7,165,006 (Indirect) | View |
| 2025-02-10 Conversion | 2025-02-10 4:28 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 7,764,670 | $0 | 3,704,959 (Indirect) | View |
Ownership | 2025-02-06 9:18 pm | N/A N/A | Sionna Therapeutics Inc. | SION | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 0 | $0 | 3,154,959 (Indirect) | View |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-10-15 Conversion | 2024-10-17 4:17 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 7,219,578 | $0 | 4,554,873 (Indirect) | View |
Ownership | 2024-10-10 8:09 pm | N/A N/A | Upstream Bio Inc. | UPB | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. Director 10% Owner | 0 | $0 | 4,868,589 (Indirect) | View |
Ownership | 2024-09-23 4:42 pm | N/A N/A | Traws Pharma Inc. | TRAW | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC 10% Owner | 0 | $0 | 1,278,469 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
Ownership | 2024-09-12 7:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |